Heart Failure — GCC Nursing Guide
Comprehensive evidence-based nursing reference covering classification, assessment, acute management, chronic care, device therapy, and GCC-specific considerations. Includes interactive daily monitoring tracker.
HFrEF / HFmrEF / HFpEF
NYHA I–IV
Acute Decompensation
Evidence-Based Therapy
GCC Context
❤️ Definition of Heart Failure
Heart failure (HF) is a clinical syndrome caused by a structural and/or functional cardiac abnormality resulting in reduced cardiac output and/or elevated intracardiac pressures. The ventricles fail to fill adequately (diastolic dysfunction) or eject sufficient blood (systolic dysfunction), or both. HF is not a diagnosis in isolation — it always has an underlying cause.
ℹ️
Key concept: HF is a syndrome (symptoms + signs + objective evidence), not simply a low ejection fraction. Patients with preserved EF (HFpEF) have significant morbidity and mortality.
📊 Classification by Ejection Fraction
Echocardiography is the cornerstone investigation for classifying HF. Left ventricular ejection fraction (LVEF) guides therapy selection.
| Type | LVEF | Key Features | Evidence-Based Therapies |
|---|
| HFrEF Reduced EF | <40% | Systolic dysfunction, dilated LV common, most studied phenotype | ACEi/ARB/ARNI, beta-blocker, MRA, SGLT2i, ICD/CRT if indicated |
| HFmrEF Mildly Reduced EF | 40–49% | Intermediate group; may improve to HFpEF or worsen to HFrEF | Consider therapies as for HFrEF; SGLT2i beneficial |
| HFpEF Preserved EF | ≥50% | Diastolic dysfunction, common in elderly, hypertensive, diabetic, obese | Treat underlying causes; SGLT2i now proven; diuretics for congestion |
EF Reference Ranges
HFpEF ≥50%
HFmrEF 40–49%
HFrEF <40%
🏃 NYHA Functional Classification
Symptom-based — can change with treatment
| Class | Description |
|---|
| I | No symptoms with ordinary activity. No limitation. |
| II | Slight limitation. Comfortable at rest. Symptoms with moderate exertion (climbing stairs, walking uphill). |
| III | Marked limitation. Comfortable at rest. Symptoms with minimal exertion (dressing, walking slowly). |
| IV | Symptoms at rest or with any activity. Bed-bound. |
⚠️
NYHA class guides diuretic titration, therapy escalation, and device decisions. Document at every encounter.
🅰️ ACC/AHA Stages
Stage is permanent — does not improve unlike NYHA
| Stage | Description |
|---|
| A | At risk for HF. No structural heart disease, no symptoms. (e.g., diabetic, hypertensive) |
| B | Pre-HF. Structural heart disease present but no symptoms. (e.g., reduced EF on echo, previous MI) |
| C | Symptomatic HF. Current or prior symptoms with structural disease. |
| D | Advanced HF. Refractory symptoms at rest despite optimal therapy. LVAD/transplant/palliative care territory. |
🔬 Common Causes of Heart Failure
Most Common Globally
- Ischaemic heart disease (IHD) — #1 cause worldwide; MI leads to myocardial scarring and systolic dysfunction
- Hypertension — leads to LV hypertrophy and diastolic dysfunction → HFpEF
- Dilated cardiomyopathy — idiopathic, familial, or secondary
Structural / Valvular
- Aortic stenosis — pressure overload → LV hypertrophy
- Mitral regurgitation — volume overload → LV dilation
- Rheumatic heart disease — still prevalent in GCC
- Congenital heart disease
Other / GCC-Relevant
- Atrial fibrillation (tachycardia-mediated cardiomyopathy)
- Diabetes mellitus — diabetic cardiomyopathy; very prevalent in GCC
- Hypertrophic cardiomyopathy
- Toxins — alcohol, anthracyclines (chemotherapy)
- Thyroid disease (hyper/hypothyroid)
- Peripartum cardiomyopathy
⚡ Acute vs Chronic HF
| Acute Decompensated | Chronic Stable |
|---|
| Onset | Hours to days | Weeks to months |
| Priority | Rapid stabilisation, diuresis, oxygenation | Optimise GDMT, self-management |
| Setting | ED, CCU, medical ward | Outpatient, HF clinic |
| Nursing focus | Hourly urine output, vitals, O2, fluid balance | Education, medication adherence, daily weighing |
🧪 BNP / NT-proBNP
Brain natriuretic peptide (BNP) and NT-proBNP are released by ventricular myocytes in response to increased wall stress (volume/pressure overload). They are the biochemical hallmark of HF.
| Marker | Rule-Out HF | Elevated (suggests HF) |
|---|
| BNP | <35 pg/mL | >100 pg/mL |
| NT-proBNP | <125 pg/mL | >300–450 pg/mL (age-adjusted) |
⚠️
Rising BNP/NT-proBNP = decompensation signal. Serial monitoring guides diuretic titration. BNP can be falsely low in obesity.
🌍 GCC HF Epidemiology
The GCC faces a triple-hit burden: high rates of ischaemic heart disease, hypertension, and type 2 diabetes — all major causes of heart failure. The Gulf CARE registry identified HF patients in the Gulf as younger than Western cohorts, with high rates of IHD as the underlying cause. Hospitalisation rates for HF are among the highest globally, with limited community follow-up infrastructure historically.
~35%
of GCC HF patients are diabetic at admission
20–30%
30-day readmission rate in GCC
~50%
of GCC HF is HFrEF (IHD-driven)
🩺 Symptom Assessment
Dyspnoea
- Classify using NYHA (see Tab 1)
- Ask: exercise tolerance — distance walked, stairs climbed
- Exertional vs resting dyspnoea
- Onset — gradual (chronic) vs sudden (acute pulmonary oedema)
Orthopnoea
- Breathlessness lying flat — fluid redistributes to lungs
- Always ask: "How many pillows do you sleep with?"
- 2+ pillows to stay comfortable = significant orthopnoea
Paroxysmal Nocturnal Dyspnoea (PND)
- Wakes from sleep with breathlessness, typically 1–3 hours after lying down
- Relieves by sitting up or opening a window
- Highly specific for left heart failure
Other Symptoms
- Peripheral oedema — ankle/leg swelling, worse in evening
- Fatigue and exercise intolerance
- Nocturia — nocturnal fluid mobilisation
- Abdominal bloating / early satiety (ascites/hepatomegaly)
- Weight gain — fluid retention
- Palpitations — arrhythmia
- Pre-syncope / syncope — low output state
🔍 Physical Examination — Nursing Role
| Finding | Technique | Significance | Action |
|---|
| Elevated JVP | Patient at 45°; look for jugular venous pulsation above clavicle. JVP >4cm above sternal angle = elevated | Raised right-sided filling pressures; fluid overload | Document height; report to medical team if new/worsening |
| Bibasal crackles | Auscultate lower lung zones bilaterally; fine crepitations that don't clear with coughing | Pulmonary congestion / interstitial oedema | Assess O2 saturation; escalate if new |
| S3 Gallop | Heard at apex with bell of stethoscope; low-pitched extra sound in early diastole | Ventricular volume overload; indicates elevated filling pressures | Highly specific for HF decompensation; document and report |
| Peripheral Oedema | Press firmly for 5 seconds over tibia/dorsum of foot/sacrum (bed-bound) | Right heart failure / venous congestion / low albumin | Grade 1–4+; measure calf/ankle circumference if available; elevate limbs |
| Hepatomegaly | Palpate right upper quadrant; tender liver edge = hepatic congestion | Right heart failure with hepatic venous congestion | Assess LFTs; tender hepatomegaly → worsening right HF |
| Ascites | Shifting dullness or fluid thrill on percussion | Right HF / portal hypertension | Abdominal girth measurement; weight monitoring |
| Hypotension | BP <90/60 or MAP <65 | Low output state; cardiogenic shock | Urgent escalation; hold vasodilators/diuretics; senior review |
Peripheral Oedema Grading
- 1+ Mild pitting, <2mm depth, resolves immediately
- 2+ Moderate, 2–4mm depth, resolves in <15 seconds
- 3+ Deep pitting, 4–6mm, resolves in 1–2 minutes, limb swollen
- 4+ Very deep pitting, >8mm, resolves in >2 minutes, brawny oedema
⚖️ Daily Weight Monitoring — The Hallmark of HF Monitoring
📌
CORE PRINCIPLE: In HF, weight changes reflect fluid status more than nutrition. Each litre of retained fluid = approximately 1 kg weight gain.
Protocol
- Weigh every morning after first void, before breakfast
- Same time each day
- Same scale — calibrate regularly
- Same clothing (or none) — light indoor clothes only
- Record in diary / HF monitoring app
- Weigh before taking diuretics
Action Thresholds
⚠️
Gain >1 kg in 24 hours → Check fluid intake; increase awareness
🚨
Gain >2 kg in 48 hours → Contact GP / HF nurse / HF team immediately. Do not wait. This indicates fluid retention requiring diuretic adjustment.
✅
Sudden weight loss of >2 kg can indicate over-diuresis — also contact HF team
📋 Fluid Balance Charting
Inputs (record all)
- Oral fluids — all drinks, soups, ice cream
- IV fluids including drug infusions
- NG/PEG feeds
- Blood products
- IV medications in fluid carriers
Outputs (record all)
- Urine — via catheter (hourly if acute HF) or measured voiding
- Vomit / NG aspirate
- Drain output
- Estimated stool (diarrhoea)
- Insensible losses (~500mL/day in afebrile patient)
⚠️
A positive fluid balance >500 mL in 24 hours in an acute HF patient = review diuretic dose. Target: negative or even balance during active diuresis phase (aim -500 to -1000 mL/day).
BNP/NT-proBNP Serial Monitoring
Monitor BNP/NT-proBNP on admission, at 24–48 hours, and at discharge. A falling BNP indicates response to treatment. Discharge BNP >700 pg/mL = high 30-day readmission risk. Serial natriuretic peptide-guided therapy improves outcomes in ambulatory HFrEF patients.
🚨 Acute Decompensated Heart Failure (ADHF)
ADHF represents a rapid worsening of HF symptoms requiring urgent hospitalisation. It is the leading cause of hospital admission in adults over 65 globally. In-hospital mortality is 4–7%. Identifying and treating the precipitant is as important as treating the congestion itself.
🔤 Precipitants of Decompensation — FAILURES Mnemonic
FAILURES — Common Triggers of Acute Decompensation
F
Forgot medications — non-adherence is the #1 precipitant; ask specifically about missed doses
A
Arrhythmia — rapid AF most common; new arrhythmia → loss of atrial kick → cardiac output drops
I
Ischaemia — new MI or demand ischaemia → acute systolic dysfunction; check ECG and troponin
L
Lifestyle — dietary indiscretion (excess salt/fluid), alcohol binge, extreme exertion
U
Upregulation of hypertension — uncontrolled BP → acute hypertensive pulmonary oedema
R
Renal failure — worsening renal function → fluid retention, electrolyte imbalance; cardiorenal syndrome
E
Embolism — pulmonary embolism → right heart strain → right HF → reduced LV filling
S
Stenosis / valve disease — new or worsening valvular disease; also anaemia, sepsis, thyroid disease
⚡ Initial Nursing Management of ADHF
Immediate Actions (first 30 minutes)
- Position: Sit patient upright (90°) — reduces venous return and work of breathing
- Oxygen: High-flow O2 if SpO2 <94%; titrate to maintain 94–98% (avoid hyperoxygenation)
- IV access: Two large-bore cannulas; blood samples (FBC, U&E, creatinine, BNP, troponin, LFT, glucose, ABG)
- 12-lead ECG: Urgently — look for AF, LBBB, ST changes
- Continuous monitoring: SpO2, cardiac monitor, NIBP every 15–30 minutes
- CXR: Portable if possible — Kerley B lines, cardiomegaly, pulmonary oedema pattern
- Urinary catheter: For hourly urine output monitoring
- Weight: If patient can stand safely; or document and weigh when able
CXR Findings in Acute Pulmonary Oedema
- A — Alveolar shadowing (bat-wing pattern)
- B — Kerley B lines (horizontal lines at lung bases)
- C — Cardiomegaly (cardiothoracic ratio >0.5)
- D — Diversion (upper lobe blood diversion)
- E — Effusion (blunting of costophrenic angles)
🚨
SpO2 <90% or worsening respiratory distress → escalate urgently; prepare for NIV (CPAP/BiPAP)
💉 IV Diuretics — Furosemide
Dosing Principles
- Furosemide IV is the mainstay of acute decongestion
- Furosemide naive: Start 40–80 mg IV bolus
- Already on oral furosemide: Give IV dose ≥ daily oral dose (e.g., on 80mg oral → give 80–160mg IV; IV bioavailability ~2× oral)
- Can give as IV bolus or continuous infusion (infusion preferred in resistant cases)
- High-dose if refractory: add metolazone (thiazide) for diuretic synergy
Nursing Monitoring
- Hourly urine output — target 200 mL/hour during active diuresis
- If urine output <100 mL/hour after 2 hours — escalate; consider dose increase or renal function check
- Electrolytes (U&E) every 12–24 hours during IV diuresis
- Potassium replacement: K+ <3.5 → replace per protocol (risk of arrhythmia)
- Magnesium: replace if <0.8 mmol/L (furosemide causes Mg loss)
- Creatinine rise (>20–30% from baseline) = worsening cardiorenal syndrome — hold or reduce diuretic
- Signs of over-diuresis: hypotension, tachycardia, dry mucous membranes, creatinine rise
⚠️
Furosemide ototoxicity risk with high doses — avoid rapid IV push of high doses (>4 mg/min). Infusion rates preferred for doses >80 mg.
💊 Vasodilators in ADHF
Nitrates (GTN / Isosorbide)
- Used in hypertensive acute HF (SBP >140 mmHg)
- Reduce preload (venodilation) and afterload (arterial dilation)
- GTN SL 400–800 mcg stat OR IV GTN infusion (start 10–20 mcg/min, titrate)
- Monitor BP every 5–15 minutes when initiating
⛔
Contraindications to nitrates: SBP <100 mmHg, right heart failure/RV infarct, phosphodiesterase-5 inhibitor use (sildenafil) within 24–48 hours, severe aortic stenosis
😮💨 Non-Invasive Ventilation (NIV)
CPAP for Cardiogenic Pulmonary Oedema
- CPAP (5–10 cmH2O) is first-line NIV for acute cardiogenic pulmonary oedema
- Mechanism: positive airway pressure → reduces venous return (preload) → improves oxygenation → recruits alveoli
- Reduces need for intubation; improves dyspnoea rapidly
- BiPAP if patient also hypercapnic
Nursing CPAP Care
- Correct mask fit — check for leaks
- Skin care — pressure areas (nasal bridge)
- Monitor SpO2, RR, HR, BP, LOC continuously
- Patient tolerance — reassure and explain
- Oral hygiene and aspiration precautions
- Have airway trolley available
💊 Evidence-Based Pharmacotherapy for HFrEF — The "Fantastic Four"
Four drug classes have proven mortality and hospitalisation benefit in HFrEF. Nursing education and monitoring of these agents is central to HF nursing practice.
| Drug Class | Example | Key Nursing Education | Hold / Caution If |
|---|
| ACEi / ARB / ARNI |
Ramipril, Candesartan, Sacubitril-Valsartan |
May cause dry cough (ACEi — switch to ARB); dizziness (hypotension); hyperkalemia; renal function monitoring. ARNI (sacubitril/valsartan) replaces ACEi/ARB in stable HFrEF — do not combine. |
SBP <90 mmHg; K+ >5.5 mmol/L; creatinine rise >50% from baseline; bilateral renal artery stenosis; pregnancy |
| Beta-Blockers |
Carvedilol, Bisoprolol, Metoprolol succinate |
Start low, go slow — titrate over weeks. Do NOT start during acute decompensation. May cause fatigue/bradycardia initially. Do not stop abruptly — can precipitate rebound hypertension/MI/decompensation. |
Active decompensation (wet/cold); HR <50; SBP <90; significant bronchospasm (use cardioselective agent cautiously); significant AV block |
| MRA (Aldosterone Antagonist) |
Spironolactone, Eplerenone |
Potassium-sparing — hyperkalemia risk (especially with ACEi/ARB). Check K+ within 1 week of starting. Spironolactone → gynaecomastia in men (switch to eplerenone if bothersome). |
K+ >5.0 mmol/L; eGFR <30; significant renal impairment; concurrent NSAIDs |
| SGLT2 Inhibitors |
Empagliflozin (Jardiance), Dapagliflozin (Farxiga) |
Reduce HF hospitalisation and cardiovascular death in both HFrEF and HFpEF. Work regardless of diabetes status. Genital mycotic infections — hygiene education. Euglycaemic DKA risk (rare but serious). Osmotic diuresis — weight loss expected. |
eGFR <20–25; recurrent UTIs; type 1 diabetes (relative); hold peri-operatively; during prolonged fasting (Ramadan considerations — see Tab 6) |
📌
Ivabradine: Added if HR >70 bpm in sinus rhythm on maximally tolerated beta-blocker. Purely heart rate reducing. No use in AF. Contraindicated if HR <60 at rest.
🥤 Fluid and Salt Restriction
Fluid Restriction
- 1.5–2 litres per day in severe HF (NYHA III–IV) or during decompensation
- Includes ALL fluids: water, juice, tea, coffee, soup, ice cream, jelly
- Measure with a jug or marked bottle at home
- Spread evenly through the day — don't restrict all at once
- Sip cold water to relieve thirst; sucking on ice chips counts as fluid intake (volume when melted)
- Hot weather / fever / exercise = increased insensible losses; may need individual adjustment
Salt (Sodium) Restriction
- Target: <2g sodium (<5g salt) per day
- No added salt at table; avoid processed, tinned, and fast foods
- Reading food labels: look for sodium per 100g — >600mg/100g = high salt
- Hidden salt: soy sauce, pickles, preserved fish, canned soups, bread
- GCC-specific high-sodium foods: Machboos, Harees, Margoog, preserved sardines/anchovies, salted cheeses, instant noodles
- Use herbs and spices instead of salt
- Low-sodium salt alternatives — caution in renal failure (high potassium)
🏃 Activity, Exercise and Cardiac Rehabilitation
Activity Prescription
- Bed rest is NOT recommended in stable HF — deconditioning worsens functional class
- Regular moderate aerobic exercise is safe and beneficial in stable HFrEF and HFpEF
- Start with short walks, gradually increase duration and pace
- Target: 150 minutes moderate activity per week if tolerated (NYHA I–II)
- Stop if: chest pain, severe dyspnoea, dizziness, HR >120 bpm at rest
- Avoid: heavy isometric exercise, extreme hot/cold environments
Cardiac Rehabilitation in HF
- Structured HF exercise rehabilitation programmes reduce hospitalisation and improve QoL
- Components: supervised exercise, education, psychological support, risk factor management
- Referral: on discharge from HF admission or in stable outpatient setting
- GCC context: Formal cardiac rehab programmes limited in public sector; growing in UAE (Cleveland Clinic, Sheikh Khalifa) and Qatar (Hamad Medical Corporation); some patients attend privately
- Remote/home-based cardiac rehab emerging post-COVID
✅ Self-Management Discharge Checklist
Tick each item as completed. Progress is saved automatically.
⚡ ICD — Implantable Cardioverter-Defibrillator
Indication
- HFrEF with LVEF ≤35%, NYHA II–III, on optimal GDMT for >3 months
- Survivors of VF/sustained VT (secondary prevention)
Post-Implant Nursing Care
- Arm restriction: Ipsilateral arm — no overhead movements or heavy lifting for 4–6 weeks (lead dislodgement risk)
- Wound care: keep dry x48h; check for haematoma, infection, wound dehiscence
- Pocket haematoma: avoid anticoagulant bridging if possible; haematoma monitoring daily
- Device check at 4–6 weeks, then 6–12 monthly
Patient Education
- Appropriate shock: Felt as a "punch in the chest" — normal function; call HF team after first shock
- Inappropriate shock: ICD fires for non-VT/VF (AF, T-wave oversensing) — distressing; needs urgent review
- Magnet: Placing a magnet over ICD inhibits shock delivery — used at end of life or during surgery
- MRI: Most modern ICDs are MRI-conditional — confirm with device ID card before scan
- Driving restrictions: follow local regulations (usually 6 months off driving after appropriate shock)
- Electromagnetic interference: mobile phones >15 cm from device; avoid arc welding, strong magnets
🔋 CRT — Cardiac Resynchronisation Therapy
Indication
- HFrEF LVEF ≤35%, NYHA II–III, QRS ≥150 ms with LBBB pattern, on optimal GDMT
- CRT-D = CRT + ICD function (most common); CRT-P = CRT pacemaker only
Mechanism
Biventricular pacing — synchronises left and right ventricular contraction → improves cardiac output. Can reverse LV remodelling over months (LVEF may improve).
Nursing Care
- Same post-implant wound and arm care as ICD
- Pocket haematoma: monitor closely — CRT has 3 leads (higher haematoma risk)
- Resynchronisation takes weeks to months to show full effect — reassure patient
- Remote monitoring data review — intrathoracic impedance (OptiVol/CorVue) can detect fluid build-up 10–14 days before clinical decompensation
Remote Monitoring
- Patient transmits device data nightly via bedside communicator
- Nurse reviews: arrhythmia burden, pacing percentages, intrathoracic impedance trend, patient weight (if linked scale)
- Alerts to HF team if fluid trend detected
🤖 LVAD — Left Ventricular Assist Device
LVAD is a mechanical pump implanted to support failing LV in Stage D HF. Used as bridge-to-transplant (BTT), bridge-to-decision, or destination therapy (DT — permanent implant when transplant not possible).
Driveline Care (Critical)
- Driveline exits through abdominal skin and connects to external controller
- Driveline infection is the most serious complication — can lead to pump failure and death
- Sterile or clean dressing technique per protocol — typically weekly (or sooner if loose/soiled)
- Assess exit site: redness, swelling, discharge, granulation tissue
- Immobilise driveline — prevent movement/traction at exit site
- Patient and family trained in dressing technique before discharge
Device Management
- Speed settings: Adjusted by advanced HF team; do not change without instruction
- Alarm management: Low flow alarm (suction event — reduce speed, IV fluid, check volume status); controller alarms — follow LVAD card/manual
- Anticoagulation: Warfarin — target INR 2–3; must never be subtherapeutic (pump thrombosis risk)
- Aspirin concurrently for antiplatelet effect
- Controller battery: Always carry spare batteries; charge schedule
- No MRI — LVAD is MRI unsafe
- No defibrillation directly over pump — position pads anteroposterior
🚨
LVAD Emergency: Loss of pump sounds (can auscultate with stethoscope over pump), power failure, suction alarms, stroke symptoms → immediate LVAD emergency protocol + senior review. Patient should have emergency contact card at all times.
🫀 Heart Transplant — Pre-Transplant Nursing
- Listing for transplant: UNOS/local criteria — NYHA III–IV, optimal GDMT failed, no contraindications (malignancy, severe obesity, active infection, significant comorbidity)
- Nursing role in work-up: coordinate multiple investigations (cardiac catheterisation, echo, PFTs, renal function, dental screen, cancer screen, psychosocial assessment)
- Patient education: lifelong immunosuppression, rejection signs (fever, breathlessness, fatigue), infection precautions
- Psychological support — waiting list can be months to years; anxiety and depression common
- LVAD as bridge-to-transplant — maintain LVAD care while listed
- Regular reassessment — some patients improve with GDMT/CRT and may be delisted
🕊️ Palliative Care in Advanced / End-Stage HF
- Prognosis in Stage D HF is often worse than many cancers — early palliative care integration improves QoL
- Diuretics: continue for symptom relief even at end of life — prevent intractable dyspnoea and oedema
- Opioids (low-dose morphine): effective for refractory dyspnoea in end-stage HF
- ICD deactivation discussion: Patient should be informed of right to deactivate ICD shocks at end of life — shocks in dying patient cause suffering; pacemaker function can be maintained separately
- Advance care planning: document resuscitation decisions (DNAR/DNI), preferred place of death
- Symptom burden assessment: dyspnoea, fatigue, pain, anxiety — regular review
- Family/caregiver support and education
- GCC context: death and dying discussions can be culturally sensitive — involve family and patient sensitively; spiritual care support
🌍 GCC Heart Failure Epidemiology — GULF CARE Registry
The GULF CARE (Gulf aCute heArt failuRE) registry is the largest multinational HF registry in the Gulf region, enrolling patients from Oman, UAE, Qatar, Saudi Arabia, Yemen, and Kuwait. Key findings:
Younger
GCC HF patients ~10 years younger than European/US cohorts — IHD in productive working age
IHD #1
Ischaemic heart disease is the leading HF aetiology in GCC — reflecting high cardiovascular risk factor burden
High DM
~35–40% HF patients have diabetes; GCC has one of the highest T2DM prevalence rates globally
20–30%
30-day readmission rate — among highest globally; community follow-up infrastructure historically limited
Under-treated
Lower rates of evidence-based therapies (beta-blockers, ACEi) at discharge vs Western registries in early GULF CARE data
Improving
HF specialist clinics and nurse-led programmes growing in UAE, Qatar, KSA — Cleveland Clinic Abu Dhabi, Hamad HF Programme, King Faisal Specialist Hospital
👩⚕️ HF Nurse Specialist Role in GCC
The HF Nurse Specialist (HFNS) role is emerging but growing across the GCC, modelled on established UK/European HF nurse programmes (which have demonstrated reduced mortality and readmission).
Established Programmes
- Cleveland Clinic Abu Dhabi — HF Advanced Care Clinic with nurse coordinators, remote monitoring
- Hamad Medical Corporation (Qatar) — HF programme with dedicated nursing, outreach follow-up
- King Faisal Specialist Hospital, Riyadh — LVAD and transplant nursing programmes
- American Hospital Dubai — private sector HF nurse-led clinics
HF Nurse Specialist Core Competencies
- Titration of GDMT medications under prescribing protocol or physician supervision
- Remote monitoring review (device data, weights, BNP trends)
- HF self-management education (weight, fluid, diet, activity)
- Telephone/telemedicine follow-up clinic
- Early identification of decompensation and proactive management
- Coordination of care across cardiology, nephrology, diabetes team
- Advanced care planning and palliative care coordination
🌙 Ramadan and Heart Failure
Ramadan fasting (typically 12–18 hours/day, up to 30 days) creates specific challenges for HF patients. Nursing guidance before Ramadan is essential.
Risks During Ramadan
⚠️
Dehydration risk: Prolonged fasting + hot GCC climate = significant fluid and electrolyte loss — can worsen renal function and precipitate hypotension/decompensation
⚠️
Fluid overload at Iftar: Rapid intake of large volumes of fluid/food at Iftar and Suhoor can overwhelm the failing heart — acute decompensation
- Disrupted sleep → sympathetic activation → BP changes
- Medication timing disruption — especially diuretics
- Reduced monitoring — patients may weigh less or delay seeking help
- SGLT2 inhibitors — risk of DKA or dehydration during prolonged fasting (discuss holding with physician)
Ramadan HF Nursing Guidance
- Pre-Ramadan assessment: review HF stability; advise those with NYHA III–IV, recent admission, or severe HF NOT to fast (seek religious scholar input — Islamic exemptions for illness)
- Diuretics: Consider switching from twice-daily to once-daily; take after Iftar (evening) rather than morning — allows voiding during non-fasting hours
- Fluid management during Ramadan: Spread fluid intake over Iftar-to-Suhoor window; avoid large fluid boluses at Iftar; continue monitoring
- Daily weighing: Weigh after Suhoor (pre-fast); maintain consistent timing
- Salt at Iftar: Traditional Ramadan foods (dates, broth, salty foods) — counsel on sodium intake
- Increase monitoring frequency during Ramadan (more frequent clinic/phone contact)
🍽️ GCC Diet and Heart Failure — Cultural Considerations
| Traditional Food | Country | HF Concern | Nursing Advice |
|---|
| Machboos / Kabsa | UAE, Qatar, KSA | High sodium (rice cooked in broth, preserved spices, salty meat) | Use less salt in cooking; rinse rice; reduce portion size; avoid adding table salt |
| Harees | UAE, Oman, GCC-wide | High sodium if salted; large portion size; often eaten at celebrations | Limit portion; avoid adding salt; ask for no-salt preparation |
| Margoog / Thareed | UAE, GCC | Broth-based — high sodium; can be high fluid volume | Eat the solid components; avoid drinking the broth directly |
| Preserved fish (Saloona, Salted sardines) | GCC coastal regions | Very high sodium — preserved fish can contain 1000–2000mg Na per serving | Avoid or strictly limit; opt for fresh fish prepared without salt |
| Karak chai / Sweet tea | GCC-wide | High fluid volume; often with evaporated milk; multiple cups throughout day | Count as fluid intake; limit to 1–2 cups; no sugar if diabetic |
| Luqaimat / Fried sweets | GCC-wide (Ramadan) | High calorie; weight gain worsens HFpEF; sugar spikes in diabetic HF | Limit portion; avoid daily consumption |
💡
Engage the patient's family — food preparation in GCC is largely family-based. Educating the person who cooks (often a spouse, mother, or household worker) is as important as educating the patient.
💊 SGLT2 Inhibitors in the GCC Context
Evidence Summary
- EMPEROR-Reduced/Preserved (Empagliflozin): Significant reduction in CV death and HF hospitalisation in both HFrEF and HFpEF
- DAPA-HF (Dapagliflozin): Similar benefits in HFrEF; DELIVER trial extended this to HFpEF
- Beneficial regardless of diabetes status — direct cardiac and renal effects beyond glucose lowering
- Now Class I recommendation in ESC 2023 HF guidelines for HFrEF
GCC Availability and Challenges
- Cost: SGLT2 inhibitors are expensive — generic empagliflozin/dapagliflozin not yet widely available in GCC
- Insurance coverage: Growing — major insurance schemes in UAE and Qatar increasingly covering for HF indication (not just T2DM)
- Public sector: Formulary inclusion varying by country — included in KSA Ministry of Health formulary for HF; UAE MOH approving
- Ramadan: Extended fasting → dehydration + SGLT2i osmotic diuresis = risk; discuss with physician whether to hold during Ramadan
- Genital hygiene education especially important in humid GCC climate (yeast infection risk)